{"id":"https://openalex.org/W2069713699","doi":"https://doi.org/10.1016/0306-3623(94)00151-c","title":"The sigma-selective ligand NE-100 attenuates the effect of phencyclidine in a rat diving model","display_name":"The sigma-selective ligand NE-100 attenuates the effect of phencyclidine in a rat diving model","publication_year":1995,"publication_date":"1995-01-01","ids":{"openalex":"https://openalex.org/W2069713699","doi":"https://doi.org/10.1016/0306-3623(94)00151-c","mag":"2069713699","pmid":"https://pubmed.ncbi.nlm.nih.gov/7713358"},"language":"en","primary_location":{"id":"doi:10.1016/0306-3623(94)00151-c","doi":"https://doi.org/10.1016/0306-3623(94)00151-c","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0306-3623(94)00151-c","pdf_url":null,"source":{"id":"https://openalex.org/S3961818","display_name":"General Pharmacology The Vascular System","issn_l":"0306-3623","issn":["0306-3623","1879-0011"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"General Pharmacology: The Vascular System","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109316203","display_name":"Shinichi Ogawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shin-Ichi Ogawa","raw_affiliation_strings":["Department of Pharmacology, Taisho Pharmaceutical Co. Ltd., Saitama, Japan","Department of Pharmacology, Research Center, Taisho Pharmaceutical Co. Ltd, Ohmiya, Saitama 330, Japan [Tel: 048 663 1111","Fax: 048 652 7254]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Taisho Pharmaceutical Co. Ltd., Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Department of Pharmacology, Research Center, Taisho Pharmaceutical Co. Ltd, Ohmiya, Saitama 330, Japan [Tel: 048 663 1111","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Fax: 048 652 7254]","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110113221","display_name":"Shigeru Okuyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Shigeru Okuyama","raw_affiliation_strings":["Department of Pharmacology, Research Center, Taisho Pharmaceutical Co. Ltd, Ohmiya, Saitama 330, Japan [Tel: 048 663 1111; Fax: 048 652 7254]","Department of Pharmacology, Research Center, Taisho Pharmaceutical Co. Ltd, Ohmiya, Saitama 330, Japan [Tel: 048 663 1111","Fax: 048 652 7254]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Research Center, Taisho Pharmaceutical Co. Ltd, Ohmiya, Saitama 330, Japan [Tel: 048 663 1111; Fax: 048 652 7254]","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Department of Pharmacology, Research Center, Taisho Pharmaceutical Co. Ltd, Ohmiya, Saitama 330, Japan [Tel: 048 663 1111","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Fax: 048 652 7254]","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073148481","display_name":"Katsuharu Tsuchida","orcid":"https://orcid.org/0000-0002-5460-5617","observed_orcids":["https://orcid.org/0000-0002-5460-5617"]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Katsuharu Tsuchida","raw_affiliation_strings":["Department of Pharmacology, Research Center, Taisho Pharmaceutical Co. Ltd, Ohmiya, Saitama 330, Japan [Tel: 048 663 1111; Fax: 048 652 7254]","Department of Pharmacology, Research Center, Taisho Pharmaceutical Co. Ltd, Ohmiya, Saitama 330, Japan [Tel: 048 663 1111","Fax: 048 652 7254]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Research Center, Taisho Pharmaceutical Co. Ltd, Ohmiya, Saitama 330, Japan [Tel: 048 663 1111; Fax: 048 652 7254]","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Department of Pharmacology, Research Center, Taisho Pharmaceutical Co. Ltd, Ohmiya, Saitama 330, Japan [Tel: 048 663 1111","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Fax: 048 652 7254]","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112659639","display_name":"Hiroaki Araki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroaki Araki","raw_affiliation_strings":["Department of Pharmacology, Research Center, Taisho Pharmaceutical Co. Ltd, Ohmiya, Saitama 330, Japan [Tel: 048 663 1111; Fax: 048 652 7254]","Department of Pharmacology, Research Center, Taisho Pharmaceutical Co. Ltd, Ohmiya, Saitama 330, Japan [Tel: 048 663 1111","Fax: 048 652 7254]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Research Center, Taisho Pharmaceutical Co. Ltd, Ohmiya, Saitama 330, Japan [Tel: 048 663 1111; Fax: 048 652 7254]","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Department of Pharmacology, Research Center, Taisho Pharmaceutical Co. Ltd, Ohmiya, Saitama 330, Japan [Tel: 048 663 1111","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Fax: 048 652 7254]","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112817015","display_name":"Susumu Otomo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Susumu Otomo","raw_affiliation_strings":["Department of Pharmacology, Research Center, Taisho Pharmaceutical Co. Ltd, Ohmiya, Saitama 330, Japan [Tel: 048 663 1111; Fax: 048 652 7254]","Department of Pharmacology, Research Center, Taisho Pharmaceutical Co. Ltd, Ohmiya, Saitama 330, Japan [Tel: 048 663 1111","Fax: 048 652 7254]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Research Center, Taisho Pharmaceutical Co. Ltd, Ohmiya, Saitama 330, Japan [Tel: 048 663 1111; Fax: 048 652 7254]","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Department of Pharmacology, Research Center, Taisho Pharmaceutical Co. Ltd, Ohmiya, Saitama 330, Japan [Tel: 048 663 1111","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Fax: 048 652 7254]","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5110113221"],"corresponding_institution_ids":["https://openalex.org/I144245601"],"apc_list":null,"apc_paid":null,"fwci":1.0622,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.70417925,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"26","issue":"1","first_page":"177","last_page":"182"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phencyclidine","display_name":"phencyclidine","score":0.9929999709129333},{"id":"https://openalex.org/keywords/sigma-receptor-ligands","display_name":"sigma receptor ligands","score":0.6890000104904175},{"id":"https://openalex.org/keywords/ne-100","display_name":"NE-100","score":0.9900000095367432},{"id":"https://openalex.org/keywords/sigma-1-receptor","display_name":"sigma-1 receptor","score":0.6269999742507935},{"id":"https://openalex.org/keywords/sigma-2-receptor","display_name":"sigma-2 receptor","score":0.7129999995231628},{"id":"https://openalex.org/keywords/5-ht2-receptor-antagonist","display_name":"5-HT2 receptor antagonist","score":0.7170000076293945},{"id":"https://openalex.org/keywords/ritanserin","display_name":"ritanserin","score":0.902999997138977},{"id":"https://openalex.org/keywords/dopamine-d2-receptor-antagonists","display_name":"dopamine D2 receptor antagonists","score":0.6740000247955322},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.9409999847412109},{"id":"https://openalex.org/keywords/ym-09151-2","display_name":"YM-09151-2","score":0.9419999718666077},{"id":"https://openalex.org/keywords/sulpiride","display_name":"sulpiride","score":0.8410000205039978},{"id":"https://openalex.org/keywords/negative-symptoms-of-schizophrenia","display_name":"negative symptoms of schizophrenia","score":0.7379999756813049},{"id":"https://openalex.org/keywords/diving-behavior","display_name":"diving behavior","score":0.5540000200271606},{"id":"https://openalex.org/keywords/animal-models-of-schizophrenia","display_name":"animal models of schizophrenia","score":0.5580000281333923}],"concepts":[{"id":"https://openalex.org/C2777052854","wikidata":"https://www.wikidata.org/wiki/Q7512419","display_name":"Sigma receptor","level":3,"score":0.9219691157341003},{"id":"https://openalex.org/C2778851735","wikidata":"https://www.wikidata.org/wiki/Q407324","display_name":"Phencyclidine","level":4,"score":0.9101979732513428},{"id":"https://openalex.org/C2777450907","wikidata":"https://www.wikidata.org/wiki/Q3937260","display_name":"Ritanserin","level":5,"score":0.8315467834472656},{"id":"https://openalex.org/C2780806966","wikidata":"https://www.wikidata.org/wiki/Q422418","display_name":"Sulpiride","level":4,"score":0.6677649021148682},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6132413148880005},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.5882366895675659},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5789927244186401},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.5715426206588745},{"id":"https://openalex.org/C2781462491","wikidata":"https://www.wikidata.org/wiki/Q410234","display_name":"Piperidine","level":2,"score":0.5283823013305664},{"id":"https://openalex.org/C2776201271","wikidata":"https://www.wikidata.org/wiki/Q409292","display_name":"Piperazine","level":2,"score":0.4934345781803131},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.4839909076690674},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.34550565481185913},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.3298701047897339},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.32646119594573975},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.24886438250541687},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.24212563037872314},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19994598627090454},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09606519341468811}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000840","descriptor_name":"Anisoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002227","descriptor_name":"Carbazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004242","descriptor_name":"Diving","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010622","descriptor_name":"Phencyclidine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011437","descriptor_name":"Propylamines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017480","descriptor_name":"Receptors, sigma","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0306-3623(94)00151-c","doi":"https://doi.org/10.1016/0306-3623(94)00151-c","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0306-3623(94)00151-c","pdf_url":null,"source":{"id":"https://openalex.org/S3961818","display_name":"General Pharmacology The Vascular System","issn_l":"0306-3623","issn":["0306-3623","1879-0011"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"General Pharmacology: The Vascular System","raw_type":"journal-article"},{"id":"pmid:7713358","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7713358","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"General pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W80940727","https://openalex.org/W1270155518","https://openalex.org/W1534264944","https://openalex.org/W1567719012","https://openalex.org/W1810033475","https://openalex.org/W1959599154","https://openalex.org/W1974864624","https://openalex.org/W1975679961","https://openalex.org/W1978627428","https://openalex.org/W1983406670","https://openalex.org/W1988836643","https://openalex.org/W1993616139","https://openalex.org/W1996137477","https://openalex.org/W1996735957","https://openalex.org/W2008359671","https://openalex.org/W2015291249","https://openalex.org/W2020678855","https://openalex.org/W2021830607","https://openalex.org/W2028805202","https://openalex.org/W2040538157","https://openalex.org/W2066383596","https://openalex.org/W2088228783","https://openalex.org/W2089628448","https://openalex.org/W2095549087","https://openalex.org/W2118527319","https://openalex.org/W2127749802","https://openalex.org/W2141787834","https://openalex.org/W2143830678","https://openalex.org/W2158137297","https://openalex.org/W2165075766","https://openalex.org/W2244471909","https://openalex.org/W2253312080","https://openalex.org/W2412027062","https://openalex.org/W2412616148","https://openalex.org/W6691706042"],"related_works":["https://openalex.org/W1984954364","https://openalex.org/W2009264791","https://openalex.org/W1979029439","https://openalex.org/W2076907602","https://openalex.org/W2015408187","https://openalex.org/W1999524680","https://openalex.org/W2086915734","https://openalex.org/W1996137477","https://openalex.org/W2096913202","https://openalex.org/W2952850203"],"abstract_inverted_index":null,"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}